Home LiteratureArticle Details

PMID: 3435111 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital.

Antimicrobial agents and chemotherapy ·Vol. 31 ·No. 10 ·1987-10-00 ·Pages 1651-5

Cornaglia G, Pompei R, Dainelli B, Satta G

Abstract

The activity of ciprofloxacin was evaluated against 1,204 isolates freshly isolated in Southern Europe, including 193 isolates of 10 species never studied before. Ciprofloxacin proved more active than other quinolones and very active in absolute terms against the 10 new species and showed against the other species an activity close to that reported for isolates from other geographic areas.

MeSH Terms

Bacteria, Anaerobic/drug effects Bacterial Infections/microbiology Ciprofloxacin/pharmacology Humans Italy

Chemicals

Ciprofloxacin

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Cornaglia G

Istituto di Microbiologia, Università degli Studi di Cagliari, Italy.

Pompei R

Dainelli B

Satta G

References (16)

16 references, click to expand

Recognition of group D streptococcal species of human origin by biochemical and physiological tests.
Appl Microbiol. 1972 Jun;23(6):1131-9 PMID: 4557563
In vitro susceptibilities of four species of coagulase-negative staphylococci.
Antimicrob Agents Chemother. 1986 Oct;30(4):545-52 PMID: 3539009
Simplified lyogroup system, a new method for routine identification of staphylococci: description and comparison with three other methods.
J Clin Microbiol. 1980 Jul;12(1):63-8 PMID: 6999015
In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
Eur J Clin Microbiol. 1983 Apr;2(2):111-5 PMID: 6222896
In vitro activity of ciprofloxacin (Bay o 9867).
Antimicrob Agents Chemother. 1983 Oct;24(4):568-74 PMID: 6228192
Activity of ciprofloxacin (BAYo 9867) against Pseudomonas aeruginosa and ampicillin-resistant Enterobacteriaceae.
Infection. 1983 Nov-Dec;11(6):326-8 PMID: 6421743
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
Antimicrob Agents Chemother. 1984 Mar;25(3):319-26 PMID: 6232895
In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.
Antimicrob Agents Chemother. 1984 Mar;25(3):331-5 PMID: 6721464
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
Antimicrob Agents Chemother. 1984 May;25(5):633-7 PMID: 6233935
Comparative in-vitro activity of quinolone carboxylic acids against Proteeae.
J Antimicrob Chemother. 1984 Nov;14(5):485-9 PMID: 6511707
Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens.
J Clin Microbiol. 1985 Jan;21(1):46-76 PMID: 3881471
Comparative in-vitro activity of ciprofloxacin against non-fermenters.
J Antimicrob Chemother. 1985 Apr;15(4):457-62 PMID: 3159710
Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks.
J Clin Microbiol. 1985 Jun;21(6):880-3 PMID: 3159749
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
Antimicrob Agents Chemother. 1985 Oct;28(4):581-6 PMID: 3000292
In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
Chemotherapy. 1985;31(6):466-71 PMID: 2934234
Simplified scheme for routine identification of human Staphylococcus species.
J Clin Microbiol. 1975 Jan;1(1):82-8 PMID: 170303

Article Info

Journal

Antimicrobial agents and chemotherapy

Abbr.

Antimicrob Agents Chemother

ISSN

0066-4804

DOI

10.1128/AAC.31.10.1651

Published

1987-10-00

Pages

1651-5

Language

English

Region

United States

NLM ID

0315061

PMCID

PMC175009

Subset

External Links

PubMed source DOI: 10.1128/AAC.31.10.1651 PMC Full Text View journal details

Analysis Services

In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital.

Contact

WeChat Official Account